Rising Demand for Prostheses and Implants Driving Medical Biomimetics Industry valuation of US$ 63.15 Billion By 2033 | FMI

During the forecast period 2023-2033, the medical biomimetics industry is expected to grow at a value of 7% CAGR, according to Future Market Insights. By the year 2033, the global market for medical biomimetics is expected to rise up to a market valuation of US$ 63.15 Billion. Growing advancement in nanotechnology, increasing demand for prostheses and implant, rise in R&D activities associated with medical biomimetics and strategic activities by key market players are the major factors which are likely to drive the market growth.

Diseases affecting the cornea are most important cause of blindness across the globe. According to the WHO, around 2 million new cases of corneal blindness are reported every year. More than 30 million people across the globe are blind in one or both eyes from corneal disease and injury, while several suffer from degraded visual acuity. Numerous attempts to create reliable, robust, and scalable solutions for artificial cornea have been unsuccessful.

Request A Sample Copy of This Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-15894

As such, there exists an unmet need, the research and development activities are being carried out for affordable and long-lasting solutions for pathology, injury, and corneal blindness. For instance, in March 2022, researchers from the Centre for LV Prasad Eye Institute, IIT-Hyderabad and Cellular, and Molecular Biology developed an exclusive biomimetic corneal hydrogel, manufactured from discarded human corneas, which can be used for the treatment of corneal scarring, the main cause of corneal blindness.

Furthermore, with the escalating number of accidents, the implementation of biomimetics for orthopaedics is projected to boom. According to Association for Safe International Road Travel, every year about 20 to 50 million people worldwide suffer from injuries that leads to permanent disability. Hence, such factors are estimated to impact positively the growth of the medical biomimetics industry.

Key Takeaways from the Market Study:

• By product, cardiovascular segment is expected to possess 43% market share for medical biomimetics industry in 2023
• By application, the wound healing segment is expected to dominate the medical biomimetics industry and expected to account for 35% market share in 2023
• North America is expected to possess 40% market share for medical biomimetics industry in 2023
• Asia Pacific is expected to possess 36% market share for medical biomimetics industry in 2023

“The increasing prevalence of diseases along with development of technologically advanced equipment is contributing to medical biomimetics industry,” comments a Future Market Insights analyst.

Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-15894

Competitive Landscape:

Some of the key players in the global medical biomimetics industry include:

• Otsuka Medical Devices Group
• Stryker
• Abbott
• AVINENT Science and Technology
• SynTouch Inc.
• Osteopore International Pte Ltd
• Vandstrom, Inc.
• Biomimetics Technologies Inc
• Swedish Biomimetics 3000 ApS
• Keystone Dental Group
• LifeMatrix
• Curasan, Inc.
• CorNeat Vision

Numerous companies in the medical biomimetics industry are expanding their products in emerging markets.

• In November 2021, Osteopore has been granted a patent in China for its smart 3D biometric scaffolds. The technology was developed with scientists from NTU Singapore and was previously granted a European patent in early 2021. This patent is anticipated to create numerous research and development opportunities in the Chinese market and allows the company to tap into local expertise as part of its product advancement process.
• In April 2021, Curasan AG expanded its distribution network in Europe, the company has added Silesia Dental and Implants Diffusion International SARL to its European distribution network.

Step into the Age of Customization: Unraveling Trends in Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-15894

Key Segments Profiled in the Medical Biomimetics Industry Survey:

Type:

• Cardiovascular
• Orthopaedic
• Ophthalmology
• Dental
• Others

Application:

• Wound Healing
• Tissue Engineering
• Drug Delivery
• Other Applications

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube